Role of thrombin in the pathogenesis of atherosclerosis

Atherosclerosis is an arterial disease associated with inflammation. Thrombin is a procoagulant and proinflammatory serine protease that contributes to the pathology of atherosclerosis by enhancing the expression of cell adhesion molecules, inducing the secretion of proinflammatory cytokines, activa...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Journal of cellular biochemistry Ročník 120; číslo 4; s. 4757 - 4765
Hlavní autoři: Jaberi, Najmeh, Soleimani, Atena, Pashirzad, Mehran, Abdeahad, Hosein, Mohammadi, Fariba, Khoshakhlagh, Mahdieh, Khazaei, Majid, Ferns, Gordon A, Avan, Amir, Hassanian, Seyed Mahdi
Médium: Journal Article
Jazyk:angličtina
Vydáno: United States Wiley Subscription Services, Inc 01.04.2019
Témata:
ISSN:0730-2312, 1097-4644, 1097-4644
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Atherosclerosis is an arterial disease associated with inflammation. Thrombin is a procoagulant and proinflammatory serine protease that contributes to the pathology of atherosclerosis by enhancing the expression of cell adhesion molecules, inducing the secretion of proinflammatory cytokines, activating inflammatory responses in atherosclerotic plaques, stimulating proliferation of aortic smooth muscle cells, and exacerbating vascular lesions at sites of injury. Hence, thrombin appears to be an important target for treatment of atherosclerosis and thrombin pharmacological inhibitors have significant therapeutic potency for suppressing inflammatory responses in cardiovascular diseases. This review summarizes the proinflammatory signaling functions of thrombin as well as the therapeutic potency of thrombin inhibitors in the pathogenesis of atherosclerosis and hence their potential therapeutic value in this condition. This review summarizes the proinflammatory signaling functions of thrombin as well as the therapeutic potency of thrombin inhibitors in the pathogenesis of atherosclerosis and hence their potential therapeutic value in this condition.
Bibliografie:Najmeh Jaberi, Atena Soleimani, Mehran Pashirzad, Hosein Abdeahad, Fariba Mohammadi, and Mahdieh Khoshakhlagh have contributed equally to this study.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ISSN:0730-2312
1097-4644
1097-4644
DOI:10.1002/jcb.27771